The {pharmaceutical industry is rapidly exploring novel treatment strategies for obesity , and the emergence of semaglutide 10mg injectables represents the advancement . Healthcare professionals are now assess the likely benefits and risks associated with this higher potency formulation , notably in relation to existing lower-dose semaglutide produ